These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 93578)

  • 21. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
    Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
    Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma.
    Ziegler JL; AnderssonM ; Klein G; Henle W
    Int J Cancer; 1976 Jun; 17(6):701-6. PubMed ID: 181331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma.
    Pearson GR; Johansson B; Klein G
    Int J Cancer; 1978 Aug; 22(2):120-5. PubMed ID: 212366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen.
    Henle W; Henie G
    J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated immunofluorescence antibody titers to several herpesviruses in Burkitt's lymphoma patients: are high titers unique?
    Hilgers F; Dean AG; de-Thé G
    J Natl Cancer Inst; 1975 Jan; 54(1):49-51. PubMed ID: 163324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma.
    Mathew GD; Qualtiere LF; Neel HB; Pearson GR
    Int J Cancer; 1981 Feb; 27(2):175-80. PubMed ID: 6169655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
    Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
    J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera.
    Klein G; Pearson G; Henle G; Henle W; Goldstein G; Clifford P
    J Exp Med; 1969 Apr; 129(4):697-705. PubMed ID: 4886044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors.
    Patarroyo M; Klein E; Klein G
    Cell Immunol; 1982 Feb; 67(1):152-9. PubMed ID: 6176334
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
    Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
    Pearson G; Klein G; Henle G; Henle W; Clifford P
    J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.
    Biggar RJ; Pandey JP; Henle W; Nkrumah FK; Levine PH
    Int J Cancer; 1984 May; 33(5):577-80. PubMed ID: 6327537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
    Gunvén P; Klein G; Clifford P; Singh S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.